Missing data and censoring in the analysis of progression-free survival in oncology clinical trials.
about
The changing face of clinical trials in the personalized medicine and immuno-oncology era: report from the international congress on clinical trials in Oncology & Hemato-Oncology (ICTO 2017).Systematic bias between blinded independent central review and local assessment: literature review and analyses of 76 phase III randomised controlled trials in 45 688 patients with advanced solid tumour
P2860
Missing data and censoring in the analysis of progression-free survival in oncology clinical trials.
description
2013 nî lūn-bûn
@nan
2013 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Missing data and censoring in ...... l in oncology clinical trials.
@ast
Missing data and censoring in ...... l in oncology clinical trials.
@en
type
label
Missing data and censoring in ...... l in oncology clinical trials.
@ast
Missing data and censoring in ...... l in oncology clinical trials.
@en
prefLabel
Missing data and censoring in ...... l in oncology clinical trials.
@ast
Missing data and censoring in ...... l in oncology clinical trials.
@en
P2093
P2860
P1476
Missing data and censoring in ...... l in oncology clinical trials.
@en
P2093
R Bailey-Iacona
P2860
P304
P356
10.1080/10543406.2013.813515
P577
2013-01-01T00:00:00Z